Publication of Suppl.Prospcts

Source: RNS
RNS Number : 3960H
Investec PLC
23 November 2022


Investec Limited
Incorporated in the Republic of South Africa
Registration number 1925/002833/06
JSE share code: INL

JSE hybrid code: INPR

JSE debt code: INLV

NSX share code: IVD

BSE share code: INVESTEC

ISIN: ZAE000081949

LEI: 213800CU7SM6O4UWOZ70

Investec plc
Incorporated in England and Wales
Registration number 3633621
LSE share code: INVP

JSE share code: INP
LEI: 2138007Z3U5GWDN3MY22


Date: 23 November 2022


As part of the dual listed company structure, Investec plc and Investec Limited notify both the London Stock Exchange and the JSE Limited of matters which are required to be disclosed under the Prospectus Rules of the United Kingdom Financial Conduct Authority and/or the JSE Listing Requirements.


Re:       Publication of Base Prospectus Supplement dated 23 November 2022 in respect of the Investec plc £2,000,000,000 Euro Medium Term Note Programme


The Base Prospectus Supplement was approved by the United Kingdom Financial Conduct Authority and is available for viewing.


Please click on the link below to see the Base Prospectus Supplement:





Please note that the information contained in the Base Prospectus Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectuses as defined in the Base Prospectus Supplement) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the relevant Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectuses you must ascertain from the Base Prospectuses whether or not you are part of the intended addressees of the information contained therein.


Your right to access this service is conditional upon complying with the above requirement.










This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.